General MedicationsOralGeneric
CIPROFLOXACIN
CIPROFLOXACIN
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview CIPROFLOXACIN is listed in Drugs@FDA under application 076593 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient CIPROFLOXACIN Form and strength Tablet; Oral - 100MG Sponsor AIPING PHARM INC Submission history Latest submission status date: 2017-10-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview CIPROFLOXACIN is listed in Drugs@FDA under application 076593 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient CIPROFLOXACIN Form and strength Tablet; Oral - 100MG Sponsor AIPING PHARM INC Submission history Latest submission status date: 2017-10-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.